Author Question: In the healthcare context, the distributive justice criterion of equity refers to the _____. A) ... (Read 63 times)

OSWALD

  • Hero Member
  • *****
  • Posts: 580
In the healthcare context, the distributive justice criterion of equity refers to the _____.
 A) Collateral provided against for payment of procedures performed
  B) Fact that each healthcare service provided is of equal monetary value
  C) Equal distribution of healthcare procedures and services to all in need
  D) Resources distributed by weighing members' needs against one another

Question 2

In the healthcare context, the distributive justice criterion of ability refers to the _____.
 A) Eligibility of patients to receive services/procedures
  B) Medical stability required for a test or procedure
  C) The patient's power to pay for healthcare procedures
  D) Whether a provider is permitted to offer a service



Edwyer

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

C

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library